Kevin Wright | Authors


Robert A. Figlin, MD, Discusses 2020 Treatment Advances for Patients with RCC

December 10, 2020

The expert from Cedars-Sinai Cancer spoke about the continued integration of immunotherapy-based combination regimens, and the importance of utilizing the multidisciplinary care team to mitigate any possible toxicities that may arise.